Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management.
Key players in Digital Diabetes Management Market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel). These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, approvals, and enhancements; expansions; agreements, collaborations, and partnerships; and mergers & acquisitions.
Medtronic is the leading player in the digital diabetes management market. The company’s leading position in this market is attributed to its strong geographical presence and wide product portfolio, which includes insulin pumps, smart glucose meters, CGM systems, mobile applications, data management software, and services. Its digital diabetes management portfolio includes the MiniMed 670 System, Guardian Connect CGM System, CareLink diabetes Personal Software, and StartRight Program. In order to sustain its leading position in the market, the company focuses on launching new and innovative products and entering into partnerships and collaborations with other players in this market.
Roche Diagnostics accounted for the second-largest share of the digital diabetes management market in 2018. The company offers connected glucose meters, CGM systems, smart insulin pens, smart insulin pumps, smart insulin patches, and data management software. Under its flagship brand Accu-Check, Roche offers a variety of digital diabetes management devices and software platforms that are widely used by end users across the globe. Roche also has a wide geographic presence spanning North America, Europe, the Middle East & Africa, and the Asia Pacific. The company mainly focuses on product launches and partnerships & collaborations to maintain its leadership position in the market.
Expected Revenue Growth:
The digital diabetes management market is projected to reach USD 19.98 billion by 2024, from an estimated USD 6.87 billion in 2019, at a CAGR of 23.8%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893
Key Market Segments:
The increasing awareness about glucose monitoring; growth in the number of regulatory approvals for CGM systems; development of advanced wearable products such as closed-loop pump systems and smart insulin patches (and pipeline devices such as contact lenses and smartwatches synced with glucometers); and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery are the major factors driving the growth of the wearable devices market.
Regional Growth Analysis:
North America to dominate the digital diabetes management market. This can primarily be attributed to the high adoption of connected diabetes management devices and apps, growing demand for closed-loop systems, high adoption of remote online coaching services for diabetes management, favorable reimbursement policies, and government initiatives to promote digital health in the region.
The digital approach to diabetes is already having an impact in a range of areas.
The global digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%.
The wearable devices segment is expected to account for the largest share of the digital diabetes management devices market in 2019 On the basis of device type, the wearable devices segment is expected to account for the largest share of the market in 2019.
The large share of the market is mainly due to factors such as the increasing number of regulatory approvals for CGM systems; technological advancements such as closed-loop pump systems, smart insulin patches, and other pipeline devices; and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery in diabetes management.
The self/home healthcare segment accounted for the largest share of the digital diabetes management market in 2019 Based on end user, the self/home healthcare is expected to account for the largest share of the market in 2019.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144725893 What Driving The Global Market Growth?
At first glance, Amanda Rosengren looks like any other teenager.
She might seem fixated on her smartphone, but Amanda is doing something far more important than scrolling through her social media feeds.
Amanda has type one diabetes, and her phone — alongside a device containing a tiny wire created by Sandvik — help monitor her glucose levels without the need for daily testing.
Amanda received her diagnosis aged four, and her diabetes soon began to put pressure on her family’s life.
The sensor is among the most critical parts of the CGM, and its size is thinner than that of a needle.
Alongside the CGM, Amanda also has an insulin pump attached to her stomach, which automatically delivers the right dose of insulin according to the measurements the app recommends.
KD Market Insights (KDMI) has announced the addition of a new syndicated Market research report on the Global Medical Case Management Service Market.
This research report presents comprehensive Market dynamics including growth drivers, industry trends, Market opportunities & barriers.
The report provides Market assessment for a period of 2019-2025, with 2019 as the base year, 2020 as an estimated year and 2020-2025 as forecast period.
The Market study also presents quantitative information such as Market size, Market share, year on year growth, Market increment, compound annual growth rate (CAGR), and Market growth opportunity.Get Sample Report: https://www.kdmarketinsights.com/sample/6390KDMI study Medical Case Management Service Market also provides information on the competitive landscape which profiles major companies engaged in the Medical Case Management Service Market.
Insights presented in the report will aid readers to understand how the Medical Case Management Service Market will unfold in the years ahead.
The Market study is significant for industry stakeholders in the Medical Case Management Service Market, such as Medical Case Management Service manufacturers, raw material suppliers, distributors, and investors, and assist them in developing key business strategies for gaining share in the Market.
(Albany, US) DelveInsight has launched a new report on "Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030".DelveInsight's " Neurofibromatosis 2 Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Neurofibromatosis 2 , historical and forecasted epidemiology as well as the Neurofibromatosis 2 market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some of Neurofibromatosis type 2 Facts:As per National Organization for Rare Disorders, the estimated incidence of NF2 is 1 in 33,000 people worldwide.
The average age of onset is 18 to 24 years.
[2018]According to Children’s Tumor Foundation, most people develop symptoms in the late teen and early adult years, although about 10% of people develop symptoms during late childhood.Request for Free Sample Report: https://www.delveinsight.com/sample-request/neurofibromatosis-2-marketView Report: https://www.delveinsight.com/report-store/neurofibromatosis-2-marketScope of the ReportThe report covers the descriptive overview of Neurofibromatosis 2 , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapiesComprehensive insight has been provided into the Neurofibromatosis 2 epidemiology and treatment in the 7MMAdditionally, an all-inclusive account of both the current and emerging therapies for Neurofibromatosis 2 are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscapeA detailed review of Neurofibromatosis 2 market; historical and forecasted is included in the report, covering drug outreach in the 7MMThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Neurofibromatosis 2 marketRequest for Free Sample Report: https://www.delveinsight.com/sample-request/neurofibromatosis-2-marketView Report: https://www.delveinsight.com/report-store/neurofibromatosis-2-marketNeurofibromatosis type 2 (NF2) is a rare genetic disorder characterized by the growth of non- cancerous tumors in the nervous system.
These growths develop along the nerve that carries information from the inner ear to the brain (the auditory nerve).
The NF2 gene provides instructions for making a protein called merlin (also known as schwannomin).
Merlin surrounds and insulate nerve cells (neurons) in the brain and spinal cord.
According to the latest report by Renub Research, titled "Netherlands Diabetes Market, By Blood Glucose (SMBG) Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast" The prevalence of diabetes mellitus (DM) is proliferating in the Netherlands.
According to Renub Research analysis, Netherlands Diabetes Market is forecasted to reach USD 4.48 Billion by the year 2025.During the last decade, the Netherlands has seen an increase in the incidence of type 2 diabetes.
Accu-Chek Sugar View is the first app that checks blood glucose ranges without the need for a blood glucose meter by taking pictures with a smartphone camera.The impact of COVID-19 on Netherlands Diabetes MarketThe spending on healthcare has increased in the nation due to this the market for diabetes management will also increase according to Renub Research analysis.
This research report covers the impact of coronavirus on the diabetic market of the Netherlands.Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=netherlands-diabetes-market-p.phpMarket Summary:By CGM: The market and market share of CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement are covered in this research report.By Self Monitoring Blood Glucose Device: SMBG Market by Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement are given in the report.By Insulin Pen: The number of Insulin Pen Users, Types Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies are covered in this research report.By Insulin Pump: This research report covers Insulin Pump Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies.By Company: This research report has covered Company overview, recent developments/ initiatives and revenue analysis for B. Braun Melsungen AG, Eli Lilly and Company, Artsana S.p.A, BD, Novo Nordisk A/S, Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet Corporation, LifeScan Inc., Abbott Laboratories, DexcomInc and Roche.About Company:Renub Research is a Market Research and Consulting Company.
We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting.
We provide wide range of business research solutions that helps companies in making better business decisions.
